Full Year 2025 CVS Group PLC Q&A Transcript
All right. Good morning, everyone, and welcome to this live stream of CVS Group's full year financial results following the publication of those earlier this morning. I'm Richard Fairman, CEO. And alongside me, I've got Robin Alfonso, our CFO; and Paul Higgs, our Chief Veterinary Officer.
We have delivered further growth across our group in the past year with improved UK operations and continuing expansion of our platform in Australia. Revenue increased by 5.4% to GBP673.3 million. We faced some challenges particularly in the first half of the year with softer market conditions in the UK, but it was pleasing to see a significant improvement in the final quarter, leading to a positive full year performance with like-for-like growth of 0.2% across the group and 1% in our core practice division. And that improved trading continued into the first quarter of the new financial year.
Adjusted EBITDA increased by 9.4% to GBP134.6 million from both acquisitions and continued disciplined cost management, and adjusted
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
